SCHEMBL17907981

SCHEMBL17907981

COc1ccc2c(c1)cc1n2C(C(=O)OC(C)(C)C)C(=O)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
NR1H2 P55055 1/20 0.37
CASP1 P29466 1/20 0.35
HPGDS O60760 1/20 0.35
MAPT P10636 1/20 0.35
AKR1C3 P42330 2/20 0.34
AKR1C2 P52895 2/20 0.34
TUBB1 Q9H4B7 1/20 0.34
STS P08842 1/20 0.34
CTSL P07711 1/20 0.34
CTSB P07858 1/20 0.34
TFPI2 P48307 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17907922 0.88 KCNQ3 (0.38)
SCHEMBL17907924 0.86 NR1H2 (0.35) KDM4EALDH1A1L3MBTL1NR1H2POLB
SCHEMBL17907949 0.85 GABRA1 (0.35) ALDH1A1L3MBTL1HTR2AHTR2C
SCHEMBL17907954 0.85 NR1H2 (0.36) KDM4EALDH1A1HPGDHSD17B10NR1H2
SCHEMBL3542987 0.83 NOTUM (0.40) NR1H2
SCHEMBL13279458 0.78 CCR9 (0.34) ALDH1A1L3MBTL1HTR2AHTR2CNR1H2
SCHEMBL17907950 0.78 MAPK1 (0.33) NR1H2
SCHEMBL17907968 0.76 HDAC1 (0.34) SMN1; SMN2NR1H2CASP1MAPT
SCHEMBL1770176 0.73 KDM4E (0.34) KDM4EALDH1A1POLB
SCHEMBL4055137 0.67 NR1H2 (0.56) KDM4EALDH1A1SMN1; SMN2HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2697223-B1 7-(HETEROARYL-AMINO)-6,7,8,9-TETRAHYDROPYRIDO[1,2-A]INDOL ACETIC ACID DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS ACTELION PHARMACEUTICALS LTD (CH) 2016-07-13 EP disclosed